DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

DepoMed, Inc. (NASDAQ: DEPO)

18.73 -0.24 (-1.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DEPO $18.73 -1.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.00
Previous Close $18.96
Daily Range $18.60 - $19.19
52-Week Range $9.85 - $20.51
Market Cap $1.1B
P/E Ratio 13.84
Dividend (Yield) $0.00 (0.0%)
Volume 638,358
Average Daily Volume 1,078,776
Current FY EPS $0.57

Sector

Healthcare

Industry

Drugs

DepoMed, Inc. (DEPO) Description

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies. Website: http://www.depomedinc.com/

News & Commentary

2 Small-Cap Stocks Hedge Funds Love

See if either stock makes sense for your portfolio.

Depomed Acquires Nucynta Franchise From J&J

Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares S

Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher

Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares S

Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher

Mid-Day Market Update: U.S. Stocks Rise; SunTrust Shares Surge On Upbeat Earnings

Mid-Day Market Update: U.S. Stocks Rise; SunTrust Shares Surge On Upbeat Earnings

Depomed (DEPO) Stock Gains Today on NUCYNTA Acquisition

New Lifetime High Reached: DepoMed (DEPO)

Thursday's After-Hours: Intel, Schlumberger Move Following Earnings

Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion

3 Healthcare Stocks With Winning Charts

See More DEPO News...

DEPO's Top Competitors

DEPO $18.73 (-1.24%)
Current stock: DEPO
JNJ $102.20 (-1.50%)
Current stock: JNJ
PFE $32.45 (-1.10%)
Current stock: PFE
RHHBY $35.35 (1.83%)
Current stock: RHHBY